What Korsana Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 3 | 4 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 351,037 |
| Disposed | 0 | 0 |
| Net activity | +0 | +351,037 |
Common stock only — 3 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Graul Regina Margaret | See Remarks | Aug 14 | Withheld — tax / exercise cost · F | −48,629 | $3.79 | −$184K | 107,523 |
| Graul Regina Margaret | See Remarks | Aug 14 | Exercise / conversion · M | +55,849 | $3.30 | +$184K | 156,152 |
| Chicko Rhonda M. | Chief Financial Officer | Aug 14 | Exercise / conversion · M | +25,000 | $2.36 | +$58.9K | 25,018 |
| Hecht Peter M | Director | Jul 16 | Derivative Conversion · C | +351,037 | — | — | 910,240 |
| Higgins Michael J | Director | Mar 25 | Grant / award · A | +9,090 | $2.75 | +$25K | 30,740 |
| Hecht Peter M | Director | Mar 25 | Grant / award · A | +181,818 | $2.75 | +$500K | 559,203 |
| Slate Path Capital Lp | 10% owner | Nov 21 | Open-market sale · S | −357,880 | $1.55 | −$555K | 0 |
| Graul Regina Margaret | President | Jan 01 | Grant / award · A | +50,000 | — | — | 100,303 |
| Hecht Peter M | Director | Jan 01 | Grant / award · A | +15,000 | — | — | 377,385 |
| Hecht Peter M | Director | Dec 01 | Grant / award · A | +15,000 | — | — | 362,385 |
| Hyman Steven | Director | Nov 30 | Grant / award · A | +20,000 | — | — | 20,000 |
| Mcguire Terrance | Director | Nov 30 | Grant / award · A | +5,000 | — | — | 5,552 |
| Desouza Errol B | Director | Nov 30 | Grant / award · A | +30,000 | — | — | 30,000 |
| Desouza Errol B | Director | Nov 30 | Grant / award · A | +20,000 | — | — | 50,000 |
| Hecht Peter M | Director | Nov 30 | Grant / award · A | +20,000 | — | — | 347,385 |
| Mcguire Terrance | Director | Aug 09 | Open-market sale · S | −8 | $3.40 | −$27.2 | 0 |
| Hecht Peter M | Chief Executive Officer | May 19 | Grant / award · A | +225,000 | $8.68 | +$1.95M | 327,385 |
| Hecht Peter M | Chief Executive Officer | Jun 03 | Open-market buy · P | +823,170 | $3.28 | +$2.7M | 2,047,698 |
| Mcguire Terrance | Director | Jun 03 | Open-market buy · P | +3,322 | $3.12 | +$10.4K | 24,957 |
| Mcguire Terrance | Director | Jun 03 | Open-market buy · P | +92,831 | $3.12 | +$290K | 697,313 |
Loading...
